---
title: "Neuromodulation, Definition | MedTech Terms"
description: "Implantable devices that stimulate the nervous system to treat disease. Plain-English Market Segments definition for MedTech teams, with examples and related te"
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/neuromodulation#term",
        "name": "Neuromodulation",
        "description": "Neuromodulation includes spinal cord stimulators (chronic pain), deep brain stimulators (Parkinson's, essential tremor), sacral nerve stimulators (overactive bladder), vagus nerve stimulators (epilepsy, depression), and emerging closed-loop systems.",
        "url": "https://medtechterms.com/terms/neuromodulation",
        "termCode": "neuromodulation",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/neuromodulation#article",
        "headline": "Neuromodulation",
        "description": "Implantable devices that stimulate the nervous system to treat disease.",
        "url": "https://medtechterms.com/terms/neuromodulation",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/neuromodulation"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/neuromodulation#term"
        },
        "articleSection": "Market Segments",
        "inLanguage": "en",
        "keywords": "Neuromodulation, Market Segments, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-05",
        "dateModified": "2026-05-05",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "INS",
            "url": "https://www.neuromodulation.com/",
            "publisher": {
              "@type": "Organization",
              "name": "INS"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "AdvaMed - Industry Reports",
            "url": "https://www.advamed.org/our-work/",
            "publisher": {
              "@type": "Organization",
              "name": "AdvaMed"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "MedTech Europe - Facts & Figures",
            "url": "https://www.medtecheurope.org/datahub/",
            "publisher": {
              "@type": "Organization",
              "name": "MedTech Europe"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/pma#term",
            "name": "Premarket Approval",
            "alternateName": "PMA",
            "url": "https://medtechterms.com/terms/pma"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Market Segments",
            "item": "https://medtechterms.com/terms?cat=Market%20Segments"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Neuromodulation",
            "item": "https://medtechterms.com/terms/neuromodulation"
          }
        ]
      },
      {
        "@type": "FAQPage",
        "@id": "https://medtechterms.com/terms/neuromodulation#faq",
        "mainEntity": [
          {
            "@type": "Question",
            "name": "What cybersecurity considerations are paramount for neuromodulation devices?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Cybersecurity for neuromodulation devices involves protecting patient data, ensuring device integrity, and preventing unauthorized access to programming functions. This is crucial for both implantable components and external controllers, as outlined in FDA guidance on cybersecurity in medical devices."
            }
          },
          {
            "@type": "Question",
            "name": "How does the regulatory pathway differ for novel neuromodulation technologies like closed-loop systems?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Novel neuromodulation technologies, especially closed-loop systems, typically require more extensive clinical data and rigorous premarket review due to their advanced functionality. Substantial equivalence claims for 510(k) submissions become more challenging, often necessitating a PMA pathway."
            }
          },
          {
            "@type": "Question",
            "name": "What specific quality management system requirements apply to neuromodulation device manufacturers?",
            "acceptedAnswer": {
              "@type": "Answer",
              "text": "Manufacturers of neuromodulation devices must adhere to comprehensive quality management system regulations such as 21 CFR Part 820 (cGMP) in the U.S. and ISO 13485 internationally. These regulations cover design controls, risk management, production, and post-market surveillance."
            }
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Market Segments](/terms?cat=Market%20Segments)
6.  /
7.  Neuromodulation

[All terms](/terms)

Market Segments [Strategic Landscape](/ecosystems/strategic-landscape)

# Neuromodulation

Implantable devices that stimulate the nervous system to treat disease.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 

## Definition

Neuromodulation includes spinal cord stimulators (chronic pain), deep brain stimulators (Parkinson's, essential tremor), sacral nerve stimulators (overactive bladder), vagus nerve stimulators (epilepsy, depression), and emerging closed-loop systems. 

What the regulation says

Neuromodulation devices are regulated as active implantable medical devices by authorities such as the FDA, often subject to  [premarket approval](/terms/pma) (PMA) due to their high-risk classification. The EU  [MDR](/terms/mdr-reporting) also classifies these as high-risk (Class III) devices, requiring  [notified body](/terms/notified-body) conformity assessment. Specific standards like ISO 14708 series apply to active implantable medical devices, covering aspects from quality management to electromagnetic compatibility. 

## What this means in practice

Medtronic, Abbott, Boston Scientific, and Nevro lead. Closed-loop and BCI (Neuralink, Synchron, Blackrock) are expanding the frontier. 

## Examples

-   A company developing a new spinal cord stimulator must submit a Premarket Approval (PMA) application to the FDA, including extensive clinical data demonstrating safety and effectiveness.
-   A manufacturer updating the software for a deep brain stimulator must assess the cybersecurity implications and ensure compliance with relevant guidance documents, such as those from the FDA.
-   To market a vagus nerve stimulator in Europe, a manufacturer must obtain CE marking through a Notified Body, demonstrating conformity with the EU MDR Annex I requirements.

Common pitfalls

-   • A common pitfall is underestimating the complexity of software validation for closed-loop neuromodulation systems. 
-   • Failing to adequately address cybersecurity risks for wirelessly connected neuromodulation implants can lead to significant regulatory hurdles. 
-   • Inadequate consideration of biocompatibility for long-term implanted components can result in device recalls or adverse events. 
-   • Not thoroughly evaluating the human factors and usability of external programmers and patient controllers can impede regulatory approval. 
-   • Misinterpreting the scope of clinical evidence required for different neuromodulation indications can delay market access. 

## Frequently asked questions

What cybersecurity considerations are paramount for neuromodulation devices? 

Cybersecurity for neuromodulation devices involves protecting patient data, ensuring device integrity, and preventing unauthorized access to programming functions. This is crucial for both implantable components and external controllers, as outlined in FDA guidance on cybersecurity in medical devices. 

How does the regulatory pathway differ for novel neuromodulation technologies like closed-loop systems? 

What specific quality management system requirements apply to neuromodulation device manufacturers? 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Regulatory

Premarket Approval(PMA) 

FDA's most stringent device marketing application, required for high-risk Class III devices.





](/terms/pma)

### More in Market Segments

· Same category 

[

Market Segments

Aesthetic & Energy-Based Devices

Lasers, RF, ultrasound, cryolipolysis, and IPL systems used for medical and cosmetic indications, body contouring, hair removal, skin tightening, vascular lesions.





](/terms/aesthetics-energy-devices)[

Market Segments

AI Imaging Software

Software that analyzes medical images to triage, detect, or quantify disease.





](/terms/ai-imaging)[

Market Segments

Cardiac Rhythm Management(CRM) 

Implantable and external devices that monitor and treat cardiac arrhythmias, pacemakers, ICDs, CRT devices, and insertable cardiac monitors.





](/terms/cardiac-rhythm-management)[

Market Segments

Cardiovascular Devices

Devices for diagnosing, monitoring, or treating cardiovascular disease.





](/terms/cardiovascular)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Strategic Landscape](/ecosystems/strategic-landscape)

## Mentioned in recent activity

7 entries 

FDA 510(k) (1)Recalls (3)Trials (3)

[Portable Neuromodulation Stimulator (PoNS) ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253061)

Helius Medical, Inc. · 2026-05-13 

## Latest in MedTech

[View all](/latest?term=neuromodulation)

Recent regulatory actions, publications, and trials matched to this term. Updated daily.

-   Trial 2026-06-01 
    
    [Sensory Synchronized Imaging and Neuromodulation ](https://clinicaltrials.gov/study/NCT06548113)
    
    VA Office of Research and Development · NOT\_YET\_RECRUITING
    
-   510(k) 2026-05-13 
    
    [Portable Neuromodulation Stimulator (PoNS) ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K253061)
    
    Helius Medical, Inc.
    
-   Recall 2026-05-13 
    
    [Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimulator, electrical, implanted, for parkinsonian tremor ](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRES/res.cfm?id=Z-2240-2026)
    
    Class II · Medtronic Neuromodulation
    

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

INS· 1 AdvaMed· 1 MedTech Europe· 1 

1.  [1 
    
    INS
    
    Verified 
    
    INS · neuromodulation.com 
    
    
    
    ](https://www.neuromodulation.com/)
2.  [2 
    
    AdvaMed - Industry Reports
    
    Verified 
    
    AdvaMed · advamed.org 
    
    
    
    ](https://www.advamed.org/our-work/)
3.  [3 
    
    MedTech Europe - Facts & Figures
    
    Verified 
    
    MedTech Europe · medtecheurope.org 
    
    
    
    ](https://www.medtecheurope.org/datahub/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Building a connected device in this segment?

Blue Goat Cyber specializes in MedTech cybersecurity across imaging, cardiac, IVD, surgical, and other connected segments.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Market Segments

Sources

3

Updated

5/5/2026

[Compare with another term](/compare?a=neuromodulation)

Learn in 60 seconds

Card Lesson Quiz

Implantable devices that stimulate the nervous system to treat disease.

-   · Medtronic, Abbott, Boston Scientific, and Nevro lead. 
-   · Closed-loop and BCI (Neuralink, Synchron, Blackrock) are expanding the frontier. 

Remember this

Watch out: A common pitfall is underestimating the complexity of software validation for closed-loop neuromodulation systems.

Related terms

-   [Premarket Approval(PMA) ](/terms/pma)

You may also need

Auto-suggested from Market Segments and shared keywords.

-   [Brainjacking ](/terms/brainjacking)
-   [Digital Therapeutics(DTx) ](/terms/digital-therapeutics)
-   [Respiratory Devices ](/terms/respiratory-devices)
-   [Urology Devices ](/terms/urology-devices)
-   [Wound Care ](/terms/wound-care)
-   [AI Imaging Software ](/terms/ai-imaging)

[All Market Segments terms](/terms?cat=Market%20Segments)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)